A framework for cancer surveillance in Japan.

J Epidemiol

Statistics and Cancer Control Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo, Japan.

Published: November 2005

The World Health Organization (WHO) has recommended that countries develop national cancer control programs in order to reduce the number of deaths due to preventable cancers. The national cancer control program should be comprehensive and systematic with evidence-based priority-setting and the efficient use of limited resources. In order to provide evidence-based information, cancer surveillance systems must be established with registration as a focus. Cancer registration monitors the incidence, mortality, survival, and prevalence of cancers. In Japan, however, cancer registration systems have not been either well developed or standardized until recently. In 2003, the Ministry of Health, Labour and Welfare of Japan launched the Third Term Comprehensive 10-Year Strategy Program for Cancer Control, which gave grants to several projects to enhance the dissemination and standardization of cancer registries. However, the establishment of a cancer registration system is merely the first step in the process to provide a comprehensive surveillance system that leads to a national cancer control program, as proposed by the WHO. To provide the best cancer care services equitably in Japan, cancer surveillance systems should be established without delay.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904377PMC
http://dx.doi.org/10.2188/jea.15.199DOI Listing

Publication Analysis

Top Keywords

cancer control
16
cancer surveillance
12
national cancer
12
cancer registration
12
cancer
11
control program
8
surveillance systems
8
systems established
8
japan cancer
8
framework cancer
4

Similar Publications

Background: Malnutrition is common with esophagogastric cancers and is associated with negative outcomes. We aimed to evaluate if immunonutrition during neoadjuvant treatment improves patient's health-related quality of life (HRQOL) and reduces postoperative morbidity and toxicities during neoadjuvant treatment.

Methods: A multicenter double-blind randomized controlled trial (RCT) was undertaken.

View Article and Find Full Text PDF

Diagnosis of lung cancer using salivary miRNAs expression and clinical characteristics.

BMC Pulm Med

January 2025

Universal Scientific Education and Research Network (USERN), Tehran, Iran.

Objective: Lung cancer (LC), the primary cause for cancer-related death globally is a diverse illness with various characteristics. Saliva is a readily available biofluid and a rich source of miRNA. It can be collected non-invasively as well as transported and stored easily.

View Article and Find Full Text PDF

The association between Chlamydia pneumoniae infection and prognosis in lung cancer patients: a prospective study.

BMC Infect Dis

January 2025

Department of Epidemiology and Health Statistics, School of Public Health, Fujian Medical University, Fuzhou, China.

Background: The prognostic value of Chlamydia pneumoniae (Cpn) infection in postoperative lung cancer patients remains unclear. This study aimed to evaluate the association between Cpn infection and survival in lung cancer patients.

Methods: This study included 309 newly diagnosed primary lung cancer patients from three hospitals in Fuzhou, China.

View Article and Find Full Text PDF

Background: Gestational exposure to non-persistent endocrine-disrupting chemicals (EDCs) may be associated with adverse pregnancy outcomes. While many EDCs affect the endocrine system, their effects on endocrine-related metabolic pathways remain unclear. This study aims to explore the global metabolome changes associated with EDC biomarkers at delivery.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!